Menu
GeneBe

ST6GALNAC3

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3, the group of Sialyltransferases

Basic information

Region (hg38): 1:76074745-76634603

Previous symbols: [ "SIAT7C" ]

Links

ENSG00000184005NCBI:256435OMIM:610133HGNC:19343Uniprot:Q8NDV1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ST6GALNAC3 gene.

  • Inborn genetic diseases (13 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ST6GALNAC3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
13
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 0 0

Variants in ST6GALNAC3

This is a list of pathogenic ClinVar variants found in the ST6GALNAC3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-76074876-A-G not specified Uncertain significance (Dec 15, 2022)2335311
1-76313809-A-G not specified Uncertain significance (Jan 29, 2024)3170677
1-76313862-C-T not specified Uncertain significance (Jan 23, 2023)2467916
1-76313863-G-A not specified Uncertain significance (Jun 22, 2021)2381812
1-76313930-A-G not specified Uncertain significance (Jun 05, 2023)2568605
1-76313936-C-A not specified Uncertain significance (Oct 25, 2023)3170676
1-76412234-C-T not specified Uncertain significance (Mar 11, 2022)2278212
1-76412245-A-C not specified Uncertain significance (Sep 16, 2022)2411564
1-76412269-C-T not specified Uncertain significance (Nov 06, 2023)3170678
1-76412353-G-A not specified Uncertain significance (Dec 21, 2023)2378249
1-76412372-T-C not specified Uncertain significance (Sep 22, 2022)2312861
1-76627490-C-T not specified Uncertain significance (Jan 29, 2024)3170679
1-76627519-G-A not specified Uncertain significance (Jan 05, 2022)2204614
1-76628689-T-A not specified Uncertain significance (Oct 12, 2021)2284390
1-76628690-C-A not specified Uncertain significance (Oct 12, 2021)2284648
1-76628708-T-C not specified Uncertain significance (Apr 11, 2023)2536187
1-76628784-A-T not specified Uncertain significance (Nov 12, 2021)2261202

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ST6GALNAC3protein_codingprotein_codingENST00000328299 5559883
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002640.9371257260221257480.0000875
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4491611780.9050.000009522010
Missense in Polyphen4874.6110.64333843
Synonymous0.2756163.80.9560.00000359568
Loss of Function1.67815.00.5348.29e-7175

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001200.000120
Ashkenazi Jewish0.000.00
East Asian0.00005460.0000544
Finnish0.00009250.0000924
European (Non-Finnish)0.0001230.000123
Middle Eastern0.00005460.0000544
South Asian0.000.00
Other0.0003490.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the biosynthesis of ganglioside GD1A from GM1B. Transfers CMP-NeuAc with an alpha-2,6-linkage to GalNAc residue on NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc of glycoproteins and glycolipids. ST6GalNAcIII prefers glycolipids to glycoproteins (By similarity). {ECO:0000250}.;
Pathway
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human);Globo Sphingolipid Metabolism;Post-translational protein modification;Metabolism of proteins;Sialic acid metabolism;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Termination of O-glycan biosynthesis;O-linked glycosylation of mucins;O-linked glycosylation (Consensus)

Recessive Scores

pRec
0.104

Intolerance Scores

loftool
0.686
rvis_EVS
-0.16
rvis_percentile_EVS
41.91

Haploinsufficiency Scores

pHI
0.291
hipred
N
hipred_score
0.443
ghis
0.503

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.316

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
St6galnac3
Phenotype

Gene ontology

Biological process
ganglioside biosynthetic process;protein glycosylation;glycosylceramide metabolic process;glycosphingolipid metabolic process;glycoprotein metabolic process;sialylation
Cellular component
Golgi membrane;nucleoplasm;integral component of membrane
Molecular function
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity;sialyltransferase activity;(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity